Voyager Therapeutics Reaches Analyst Target Price
June 19, 2019 at 08:00 AM EDT
In recent trading, shares of Voyager Therapeutics Inc (VYGR) have crossed above the average analyst 12-month target price of $27.60, changing hands for $27.88/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..